Developmental toxicity of ribavirin/IFalpha combination therapy: is the label more dangerous than the drugs?
Polifka
Janine E
JE
Friedman
J M
JM
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000818:Animals; D000998:Antiviral Agents / Q000633:toxicity*; D006224:Cricetinae; D004348:Drug Labeling / Q000592:standards*; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage / Q000633:toxicity*; D008253:Macaca mulatta; D008297:Male; D051379:Mice; D018812:Paternal Exposure; D011247:Pregnancy; D011817:Rabbits; D051381:Rats; D012254:Ribavirin / Q000008:administration & dosage / Q000633:toxicity*; D013723:Teratogens / Q000633:toxicity*
D000998:Antiviral Agents; D016898:Interferon-alpha; D013723:Teratogens; D012254:Ribavirin